The Digital Medicine Society (DiMe) announced today a new collaboration with Acclinate, Amgen, GSK, Lightship, Medable, Rubix LS, Sage Bionetworks, Savvy Cooperative, and THREAD Research to drive inclusion in digital clinical trials. The initiative aims to provide the tools and framework necessary to successfully integrate diverse perspectives during the planning process for trials that include a technology device for participation.
Any time an administration changes hands, industries across the country brace for shifts in policy and regulatory oversight. This is particularly true...
Research has the power to transform lives. It’s the driving force behind medical breakthroughs, public health improvements, and overall well-being. Bu...
Key Takeaways and Learnings Stronger clinical research depends on including a wide range of participants to ensure treatments, including targeted ther...
Key Takeaways and Learnings The recent FDA diversity in clinical trials guidance emphasizes how sponsors plan on reaching specific representation goal...
Key Takeaways and Learnings Inclusive clinical trials are essential to addressing health disparities in underrepresented communities. Building trust t...
Key Takeaways and Learnings Engaging communities through trusted relationships fosters meaningful participation in research. AI and predictive analyti...
Key Takeaways and Learnings As advanced data analytics and AI take hold in healthcare, sponsors shouldn’t overlook the potential to predict who will e...
